Nothing sinister here - more indicative of a growing and more complex company operations with expanding verticals.

Senior Management Appointments

Pro Medicus Limited (ASX: PME) is pleased to announce the following senior management

changes effective 16 March 2026.

Mr Clayton Hatch, who has held the role of Chief Financial Officer since June 2012, will assume

newly created dual roles of Head of Business Operations and Head of Investor Relations. He

will be responsible for overseeing operational initiatives within the Company, driving growth and

enhancing productivity, performance and profitability. He will also be responsible for managing

communications between the Company and its investors.

Ms Danny English will become the Chief Financial Officer succeeding Mr Hatch. Ms English

has been employed by the Company since March 2015, commencing as Group Financial

Controller before being promoted to the Head of Finance and Company Secretary three years

ago. She has extensive global financial management experience, with a deep understanding of

ASX financial reporting, governance and risk management. Danny has worked in both private

and publicly listed companies and is well versed in the complexities of dealing with both global

and local requirements, having worked in senior-level Finance roles for several years in London

and New York.

Dr Hupert, CEO congratulated Clayton Hatch on his promotion, which is recognition of his deep

knowledge of the company’s operations and investors and said: “Danny’s promotion to company

CFO reflects her extensive financial expertise that she has developed over many years.

Dr Hupert added “These management changes underscore our deliberate approach to

succession planning and highlights the depth of talent within our team. I congratulate both

Clayton and Danny on their well-deserved promotions and I look forward to working with them in

their new roles to achieve our key objective of being the leading provider of best-in-class

enterprise medical imaging solutions.”